Mark Egan
No más puestos en curso
Perfil
Mark Egan is Vice President of Operations for Sirna Therapeutics, Inc. He joined Sirna Therapeutics in 2001 and became Vice President of Manufacturing in December, 2003.
Dr. Egan began his career with ICI in 1990 and served as Manager of R&D Chemist and Business Project.
He received a degree in Chemistry in 1987 and a PhD in 1990 from the University of Glasgow.
Antiguos cargos conocidos de Mark Egan.
Empresas | Cargo | Fin |
---|---|---|
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | Director de Operaciones | 01/12/2006 |
ICI Group
ICI Group Industrial SpecialtiesProcess Industries ICI Group is a British company that manufactures paints and coatings. | Corporate Officer/Principal | - |
Formación de Mark Egan.
University of Glasgow | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | Commercial Services |
ICI Group
ICI Group Industrial SpecialtiesProcess Industries ICI Group is a British company that manufactures paints and coatings. | Process Industries |
- Bolsa de valores
- Insiders
- Mark Egan